Previous close | 2.40 |
Open | 5.00 |
Bid | 6.20 |
Ask | 14.90 |
Strike | 445.00 |
Expiry date | 2024-05-31 |
Day's range | 5.00 - 8.30 |
Contract range | N/A |
Volume | |
Open interest | 38 |
On May 29, 2024, Carmen Bozic, Executive Vice President and Chief Medical Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 2,280 shares of the company.
On May 28, 2024, Charles F. Wagner Jr., Executive Vice President and Chief Financial Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 3,250 shares of the company.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.